PRINCETON JUNCTION, N.J., Nov. 17 /PRNewswire/ -- EDDA Technology today
announced the commercial release of IQQA(R)-Chest software V2.0 featuring
enterprise CAD solution for digital X-ray. IQQA(R)-Chest is the only FDA
cleared system to offer real-time interactive diagnostic analysis of
digital chest X-rays using a comprehensive set of tools to support
radiologists in their identification, confirmation and quantification of
lung nodules. IQQA(R)-Chest has clinically demonstrated an ability to
improve radiologists' detection of small lung nodules (5-15mm) up to 85
percent.
Powered with the same computer-assisted detection support software of
the debut software V1.0, IQQA(R)-Chest Enterprise aims to redefine how
advanced clinical applications can and should be accessed by radiologists.
Up to now, radiologists have simply had to accept that the use of advanced
imaging software meant they would have to operate at dedicated workstations
detached from their primary PACS review stations. Although static image
results could often be sent from these stand-alone workstations back to a
PACS for review, it was still not possible to enjoy access to the full
functionality of these advanced applications at the PACS viewing station.
Responding to this clinical challenge, EDDA has developed a unique
enabling solution capable of instantly deploying the full functionality of
the IQQA(R)-Chest application on existing PACS review consoles without
additional requirement or setup effort on the workstations.
According to Dr. Edwin van Beek, Professor of Radiology, University of
Iowa Hospital and Clinics, the need for this level of performance is
particularly critical with chest radiography, the most frequently performed
imaging study. University of Iowa Hospital and Clinics, a commercial site
of EDDA's, has recently been upgraded to IQQA(R)-Chest Enterprise.
"With the number of chest X-rays we read on a daily basis, to maximize
the benefit from a CAD application will be highly dependent upon the
accessibility we have to the full application at our PACS review stations,"
added Dr. van Beek. "EDDA has cleared this hurdle with IQQA(R)-Chest
Enterprise. The immediacy we now enjoy with this tool allows us to expand
our use of the application at the University of Iowa with the prospect of
further enhancing our overall detection rate."
Dr. van Beek and his colleagues will report on a clinical study
conducted at the University of Iowa in which the software was used in their
daily practice since January 2006. The study suggests that the software
could help residents detect approximately 20% more small lung nodules. The
results have been accepted for presentation at the upcoming RSNA 2006
meeting.
"EDDA's vision of seamlessly integrating our advanced detection
analysis technology into the radiologist's softcopy reading environment to
improve workflow and support clinical decision-making is now being realized
with IQQA(R)-Chest Enterprise," said Jianzhong Qian, President and CEO of
EDDA Technology. "With the survivability of lung cancer tied heavily to
early detection, we are pleased to provide an innovative solution that can
significantly enhance the broad access of our advanced CAD application in
physicians' daily clinical practice."
EDDA Technology will feature IQQA(R)-Chest Enterprise at the upcoming
92nd Scientific Assembly and Annual Meeting of the Radiological Society of
North America (RSNA). RSNA 2006 will also provide the occasion for EDDA to
showcase another advanced imaging application, IQQA(R)-Liver. Using data
from a contrasted multiphase CT liver study, IQQA(R)-Liver provides
radiologists with comprehensive tools to review all acquired phases
simultaneously with automatic anatomic phase registration. It also provides
segmentation and measurement tools for visualizing and analyzing liver
lesions and vascular structures to support liver disease diagnosis and
preoperative assessment and planning. IQQA(R)-Liver has clearance from the
U.S. Food and Drug Administration (FDA), and Chinese State Food and Drug
Administration (SFDA).
About EDDA Technology
EDDA Technology, Inc. is an innovative clinical computer solution
provider in diagnostic imaging and analysis. EDDA offers a series of new
generation software products to enable early detection of diseases and
enhance precision in diagnosis. EDDA's goal is to deliver advanced
information analysis technologies that improve clinical workflow and
accuracy with broad accessibility. A privately held Delaware corporation,
EDDA is headquartered in Princeton Junction, New Jersey, and has a regional
office in Shanghai, China. In April 2006, EDDA entered into a strategic
partnership with Philips Medical Systems to provide advanced digital
radiography solutions to assist in the detection of lung lesions. IQQA is a
registered trademark of EDDA Technology. For further information, please
log on to http://www.edda-tech.com, or contact info@edda-tech.com or call
609-936-8282.
Editor's Note: EDDA Technology will be exhibiting their IQQA(R) Family
of Products in Booth #3271 in the South Hall of McCormick Place in Chicago,
Illinois, at the 92nd Scientific Assembly and Annual Meeting of the
Radiological Society of North America (RSNA), Nov. 26 - Dec. 1, 2006.
SOURCE EDDA Technology, Inc.
 back to top
Related links:
http://www.edda-tech.com
CONTACT:
Xiaolan Zeng, EDDA Technology, Inc.,
+1-609-936-8282 ext. 106
|
